17 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Company Limited
29 May 24
Current report (foreign)
6:29am
there will be 1.5 billion people in the world that fit in this demographic—double the number in 2022.2 This has created a tough environment for our industry
6-K
EX-99.1
TAK
Takeda Pharmaceutical Company Limited
31 May 22
Current report (foreign)
6:07am
treatment that prevented HAE attacks over an extended planned 132 week treatment period across specific HAE patient demographic and disease characteristic
6-K
uhvunbo t1
10 Feb 22
Current report (foreign)
6:03am
6-K
43nyxf2u ia8f
5 Nov 21
Current report (foreign)
6:02am
6-K
rhmqp99y5 sp
6 Aug 21
Current report (foreign)
6:06am
424B3
s6z6ex5n8 yz64124nw
14 Nov 19
Prospectus supplement
6:10am
F-4/A
j9oa1p 1o4t
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
sp9k0a1zt6nwn
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
3zfzc3a1dmgr ha
27 Jun 19
Annual report (foreign)
6:41am
20FR12B/A
9y984
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B
wtda9v5qh9g2d 6zvde
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
DRS/A
fxa7bv9a
16 Nov 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next